TEVA

#391
Teva Pharmaceutical Industries Limited American Depositary Shares
31.2550 USD
-1.11%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
31.2050
31.3450
Year Range
19.0100
37.3400
Daily Change
-1.11%
Monthly Change
+5.36%
6 month change
+63.60%
Year Change
+63.60%
Previous Close
31.6050
Open
31.3250
Bid
Ask
Low
31.2050
High
31.3450
Volume
631
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 35.9374 B
  • Employee 33 K
  • Founded N/A
  • CEO Richard Francis
  • Website www.tevapharm.com
  • Headquarter Israel
  • FIGI BBG000C0CD58
  • Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
25.79
Price to sales ratio
2.1

Teva Pharmaceutical Industries Limited American Depositary Shar

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.

News